Skip to main content
Zai Lab Limited logo

Zai Lab Limited — Investor Relations & Filings

Ticker · 9688 ISIN · KYG9887T1168 LEI · 549300P2UYQ9U5LY1T58 HKEX Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2023-04-28 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 9688

About Zai Lab Limited

http://www.zailaboratory.com

Zai Lab Limited is an innovative, research-based, commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing transformative therapies that address medical conditions with significant unmet needs. The company focuses its pipeline and development efforts across four core therapeutic areas: oncology, immunology, neuroscience, and infectious disease. Zai Lab employs a strategy of internal research and global partnerships to advance best-in-class and first-in-class medicines. A key commercial product is ZEJULA (niraparib), utilized as a maintenance treatment for ovarian cancer in markets including mainland China.

Recent filings

Filing Released Lang Actions
PROXY CARD
Regulatory Filings
2023-04-28 English
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) of shareholders for Zai Lab Limited, detailing the date, time, location, agenda items including director re-elections, auditor appointments, and voting instructions. It does not contain financial statements or detailed financial analysis but serves as an official meeting notice and proxy information. The document length is about 9959 characters, which is consistent with a detailed AGM notice. There is no indication that this is a full annual report or financial report. Therefore, the document fits the category of AGM Information (AGM-R).
2023-04-28 English
DEFINITIVE PROXY STATEMENT/CIRCULAR FOR 2023 ANNUAL GENERAL MEETING
Regulatory Filings
2023-04-28 English
2022 Environmental, Social, and Governance Report
Environmental & Social Information Classification · 100% confidence The document is titled 'Trust for Life 2022 ESG Report' and contains extensive content related to Environmental, Social, and Governance (ESG) factors, including sections on materiality assessment, sustainability goals, social responsibility, governance practices, and environmental impact. It references standards such as the Global Reporting Initiative (GRI) and Sustainability Accounting Standards Board (SASB), and discusses the company's ESG strategy and progress. There is no indication of financial statements, audit opinions, earnings data, or regulatory filings. The content aligns with a detailed ESG report rather than a financial or regulatory filing. Therefore, the document fits the category of Environmental & Social Information (SR).
2023-04-27 English
2022 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is titled '2022 Annual Report' and contains detailed sections typical of a full annual report, including corporate information, forward-looking statements, business overview, risk factors, chairperson's statement, financial summary, management discussion and analysis, directors and senior management, corporate governance report, independent auditor's report, and consolidated financial statements. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement. The presence of comprehensive financial and management information confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K).
2023-04-27 English
DATE OF PUBLICATION OF FIRST QUARTER 2023 RESULTS ANNOUNCEMENT
Report Publication Announcement Classification · 95% confidence The document is an announcement from Zai Lab Limited regarding the date of publication of their first quarter 2023 results. It states that the Audit Committee will approve the unaudited quarterly results for the three months ended March 31, 2023, and that the results will be announced on May 10, 2023. It also mentions a live earnings teleconference call to discuss the Q1 results. The document does not contain the actual financial results or detailed financial statements but is a notice about the upcoming release of the quarterly report and related earnings call. The document length is 2656 characters, which is relatively short and fits the pattern of an announcement rather than the report itself. Therefore, according to the rules, this is a Report Publication Announcement (RPA) rather than the Interim/Quarterly Report (IR) itself or an Earnings Release (ER).
2023-04-27 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.